Brendan Largay, Head of School

Discussion: A Step Closer to COVID Vaccine Approval For Children

Many of you have by now heard the uplifting news that on Tuesday of this week, the Food and Drug Administration announced that it has reviewed and recommended the Pfizer-Biontech vaccine for children between the ages of five and eleven after a thorough review of Pfizer’s findings on its safety and efficacy. This means that an emergency use authorization is likely to be announced in the coming days.

This is news that we have been waiting for at BDS since last March. The prospect of a vaccinated school community brings us another step closer to experiencing school as we remember it from before the pandemic. We know that there will be questions about the vaccine and what it means for our students and parents in the coming days and weeks as the rollout of the vaccine begins. We are thrilled that Belmont Day will be part of that rollout as we prepare to host a COVID-19 vaccination clinic here on campus. The date for the clinic is still to be determined, but we’re aiming for as early in November as possible.

In a generous offer of her expertise and guidance, Dr. Ingrid Katz P ’22 agreed to meet with me via Zoom for a one-on-one conversation in which we discuss everything from the expected timeline of vaccine availability to the long-range impact of pediatric vaccination at BDS and globally. I hope you find the recording of this conversation helpful and that you share in my excitement at this important next step in the fight against COVID-19 for Belmont Day.

Please click here to watch the video of our discussion. 

Have a wonderful weekend, everyone!

Scroll to Top
Giving Day 2023 logo

It’s BDS Giving Day—help us reach 225 gifts in 24 hours!